Recent work has suggested a mechanism by which this may occur—Schroeder et al. [27] found that in mice, the AR antagonist, flutamide, caused PCa cells to convert to a cancer stem cell (CSC) phenotype. This evidence concerns the gene AR and posterior cortical atrophy.